Summary: Here are the eight announcements from the AIDS list serve of the U.S. Food and Drug Administration, from January through March 2005.
The U.S. Food and Drug Administration distributed eight announcements on its AIDS list serve in January, February, and March 2005. Each one will be important for some of our readers. You can obtain all of these and any later announcements at the FDA HIV/AIDS List Serve Archive page,
www.fda.gov/oashi/aids/listserve/archive.html.
The eight announcements starting with the most recent are:
- Important information about Sustiva (efavirenz) and pregnancy, 2005-03-31
- Notice of important new drug interactions (Norvir or Kaletra), 2005-03-30
- Approval of Baraclude (entecavir) for treatment of chronic hepatitis B virus infection, 2005-03-30
- Updated guidelines for the use of antiretroviral agents in pediatric HIV infection, 2005-03-24
- Pegasus and Copegus indications expanded to include treatment of hepatitis C and HIV coinfection, 2005-03-02
- Drug interaction warning: Saquinavir/ritonavir and rifampin, 2005-02-08
- FDA warning -- unapproved home-use diagnostic test kits, 2005-02-07
- Tentative approval of copackaged antiretroviral for PEPFAR availability, 2005-01-26
You can also use the Archive page to subscribe to the FDA's AIDS list serve, if you want to be notified by email of future announcements when they go out.
ISSN # 1052-4207
Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.
This article was provided by
AIDS Treatment News.
It is a part of the publication AIDS Treatment News.
You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art31622.html
General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
